Evidence map›Paper›PMID 33706238›Full record

ArticleJournal of autoimmunity2021

HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.

Mehdi A Benkahla, Somayeh Sabouri, William B Kiosses, Sakthi Rajendran, Estefania Quesada-Masachs, Matthias G von Herrath

Open access · greenAbstract read
In one paragraph

Article in Journal of autoimmunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. A surviving beta cell subpopulation enriched in patients with T1D.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mehdi A BenkahlaLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA.
Somayeh SabouriLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA.
William B KiossesLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA.
Sakthi RajendranLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA.
Estefania Quesada-MasachsLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA.
Matthias G von HerrathLa Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA; Global Chief Medical Officer, Novo Nordisk, Denmark. Electronic address: Matthias@lji.org.
La Jolla Institute for Immunology · USNovo Nordisk (Denmark) · DK

Funding

Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 DiabetesR01AI092453 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Estefania Quesada Masachs · 2011 to 2026
$5.7M
TRAINING PROGRAM IN DIABETES RESEARCHT32DK007494 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SALTIEL, ALAN R. · 1986 to 2021
$4.7M
Integrated Functional Histopathology of the Diabetic Human PancreasR01AI134971 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HOMANN, DIRK, VON HERRATH, MATTHIAS G. · 2018 to 2022
$3.5M
Assessment of cytokines in human islets from patients with diabetesU01AI102370 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI VON HERRATH, MATTHIAS G. · 2012 to 2016
$2.2M
NIAID NIH HHS R01 AI092453NIAID NIH HHS R01 AI134971NIAID NIH HHS U01 AI102370NIDDK NIH HHS T32 DK007494
6 · The paper itself

Abstract

Human leukocyte antigens of class-I (HLA-I) molecules are hyper-expressed in insulin-containing islets (ICI) of type 1 diabetic (T1D) donors. This study investigated the HLA-I expression in autoantibody positive (AAB+) donors and defined its intra-islet and intracellular localization as well as proximity to infiltrating CD8 T cells with high-resolution confocal microscopy. We found HLA-I hyper-expression had already occurred prior to clinical diagnosis of T1D in islets of AAB+ donors. Interestingly, throughout all stages of disease, HLA-I was mostly expressed by alpha cells. Hyper-expression in AAB+ and T1D donors was associated with intra-cellular accumulation in the Golgi. Proximity analysis showed a moderate but significant correlation between HLA-I and infiltrating CD8 T cells only in ICI of T1D donors, but not in AAB+ donors. These observations not only demonstrate a very early, islet-intrinsic immune-independent increase of HLA-I during diabetes pathogenesis, but also point towards a role for alpha cells in T1D.

Indexed as

Gene ExpressionAutoantibodiesAutoantigensAutoimmunityBiomarkersDiabetes Mellitus, Type 1Disease SusceptibilityFluorescent Antibody TechniqueGlucagon-Secreting CellsHistocompatibility Antigens Class IHumansInsulin-Secreting CellsIslets of LangerhansPrediabetic StateProtein TransportT-Lymphocyte SubsetsAutoantibodiesAutoantigensBiomarkersHistocompatibility Antigens Class IAlpha cellsBeta cellsHLA class InPODType 1 diabetes

Identifiers

PMID33706238
PMCPMC8044030
OpenAlexW3134273333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.